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Volume 56, Number 2 Abstracts 587appropriate oversizing of endografts during endovascular repair of traumatic
injury and thoracic endovascular aortic repair planning and execution.
Midterm Outcome of Endovascular Repair of Ruptured Abdominal
Aortic Aneurysm: What Happened to Patients That Survive?
Nam T. Tran, Gabriel Wallace, Elina Quiroga, Benjamin Starnes, and
Thomas Hatsukami. Department of Surgery, University of Washington,
Seattle, Wash
Objective: Operative outcomes are improved in patients with a
ruptured abdominal aortic aneurysm (rAAA) who undergo endovascular
repair (rEVAR) compared with open surgical repair. Follow-up of these
patients, however, is lacking. We aim to characterize the midterm outcome of
rAAA patients who have been managed with endovascular techniques compared
with open surgical repair.
Methods: In an Investigational Review Board-approved prospective
study, we evaluated all patients with rAAA admitted from July 2007 to
February 2012 who survived to hospital discharge. Linear regression and
multivariable analysis models were used to evaluate outcome data, in-
cluding hospital length of stay, destination at discharge, survival, type of
surgical procedure, presence of hypotension, and demographics.
Results: A total of 118 patients were admitted to our facility with the
diagnosis of rAAA. Eight underwent comfort care, and four died in the operat-
ing room before repair. Of the remaining 106 patients, 43 had open repair and
63 were done with endovascular technique. Seventy-two patients survived to
discharge, with 21 of 43 (48%) in the open surgical group and 51 of 63 (81%)
in the endovascular group. Average length of stay was 12.3 days for the
endovascular group and 24.6 days for the open group (P  .002). Of the 72
patients who survived to discharge, 37 (51%) went home and 35 (49%) were
discharged to a skilled nursing facility. Of the 51 endovascular patients, 33
(65%) were discharged to home vs four of 21 (19%) in the open repair group.
Twenty patients died after being discharged from the hospital, of whom, seven
died30 days after discharge. Overall, the follow-up rate was 72% (59 of 72),
with 13 patients lost to follow-up with an average length of follow-up of 22.8
months. Multivariable regression analysis showed that only the type of proce-
dure performed (endovascular) was predictive of the discharge destination.
Survival at midterm follow-up was independent of type of procedure performed
and discharge destination.
Conclusions: The introduction of rEVAR has resulted in improvement
of the in-hospital survival of patients with rAAA, with more patients able to
be discharged to home compared with those undergoing open surgical
repair. At midterm follow-up, however, the survival rate of rAAA patients
was comparable between rEVAR and open surgical repair.
Ten-Year Results of Endovascular Abdominal Aortic Aneurysm Repair
(EVAR) from a Large Multicenter Registry
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The Permanente Medical Group, South San Francisco, Calif; 2Dart-
mouth-Hitchcock Medical Center, Lebanon, NH; 3Kaiser Permanente,
Oakland, Calif; 4The Permanente Medical Group, San Francisco, Calif;
5Division of Research, The Permanente Medical Group, Oakland, Calif;
and 6The Permanente Medical Group, Santa Clara, Calif
Objective: This study assessed long-term outcomes after endovascular
aneurysm repair (EVAR) in an integrated health care system.
Methods: Between 2000 and 2010, 1736 patients (86% were men)
underwent EVAR at 17 centers. Demographic data, comorbidities, and
outcomes of interest were collected. Primary outcomes were mortality and
aneurysm-related mortality (ARM). Secondary outcomes were change in
aneurysm sac size, endoleak status, major adverse events, and reintervention.
Results: Overall, mean age was 75 years, 82% were Caucasian, and 90% of
cases were elective. Urgent use of EVAR increased from 7% in the first 5 years to
12% in the latter 5 years of the study. Mean aneurysm size was 5.8 cm. Patients
were monitored for an average of 3 years (range, 1-11 years); 8% were lost to
follow-up. Intraoperatively, 5% of patients required adjunctive maneuvers for
endoleak, fixation, or flow-limiting issues. The 30-day mortality rate was 1.2%,
and the perioperative morbidity rate was 6.6%. Intraoperative type I and II
endoleaks were uncommon (2.3% and 9.3%, respectively.) Life-table analysis at
5 years demonstrated excellent overall survival of 66% and freedom from ARM
of 97%. Postoperative endoleak occurred in 30% of patients and was associated
with an increase in sac size over time (Fig). Finally, the total reintervention rate
was 15%, including 91 (5%) revision EVARs. The overall major adverse event
rate was 8% and decreased significantly from 12.3% in the first 5 years to 5.6% in
the second 5 years of the study (P .001). Overall, ARM was worse in patients
with postoperative endoleak (4.1% vs 1.8%, P .01) or undergoing reinterven-
tion (7.6% vs 1.6%, P .001).
Conclusions: Results from a real-world EVAR registry in an integrated
health care system demonstrate favorable perioperative outcomes and excellent
long-term clinical efficacy. However, postoperative endoleak and need for
reintervention continue to be challenging problems for patients after EVAR.
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rntraprocedural and Postprocedural Transarterial Sac Embolization
or Type II Endoleak
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Objective: Persistent type II endoleaks (T2E) affect up to one-third of
atients undergoing endovascular aneurysm repair (EVAR), and one-third or more
f these patients will require intervention. We present a novel technique available
ntraprocedurally and postprocedurally to prevent or treat persistent T2E.
Methods: This cohort represents a single-center and single-surgeon ex-
erience where transarterial sac embolization (TASE) for T2E was performed.
atients, upon completion angiogram for EVAR with a large T2E or for T2Es
oted on surveillance computed tomography scan with enlarging aneurysms,
nderwent placement of a catheter beyond the iliac limb of a deployed en-
ograft from groin access. Contrast was then infused into the sac to corroborate
he presence of a T2E, and subsequently, a thrombin and Gelfoam slurry with
ontrast was infused into the aneurysm sac. Since 2006, 13 patients have
ndergone TASE for intraprocedural and postprocedural T2E.
Results: Eight patients (61.5%) underwent intraprocedural TASE and five
38.5%) underwent postprocedural treatment. The median follow-up was 12
onths (range,0.0-51.3months);11.0months for the intraprocedural arm(range,
.5-30.6 months) and 13.6 months (range, 0.0-51.3) for the postprocedural
roup. No patients had further growth of their aneurysm. Three patients (23.1%)
ad stable aneurysm size, seven (53.8%) had a decrease in aneurysm diameter, one
atient had continued aneurysm growth but had a type IV endoleak upon re-
xploration, one patient had a recent TASE, and one patient was lost to follow-up.
o spinal embolization, distal embolization, ruptures, or systemic complications
ccurred during TASE.
Conclusions: We present an innovative technique of sac access and
mbolization during and after EVAR placement to treat intraprocedural and
ostprocedural endoleaks. Further study is required to evaluate the safety,
fficacy, and potential cost-savings.
ailure to Prevent Aneurysm Rupture Despite Early Diagnosis
atthew W. Mell, MD, Mark A. Hlatky, MD, Jacqueline B. Shreibati, MD, and
aurence Baker, PhD. Department of Surgery, Stanford University, Stanford,
alif
Objective: Screening and surveillance is paramount in the management of
mall abdominal aortic aneurysms (AAA). Gaps in surveillance after early diagnosis
ay lead to unrecognized AAA growth, rupture, and death. This study investigates
he prevalence and factors associated with rupture of previously diagnosed AAA.
Methods: Data were extracted from Medicare claims for patients who
nderwent AAA repair from 2006 to 2009. All relevant preoperative abdominal
maging examinations were tabulated 5 years before AAA repair. Repair for
uptured AAA was compared with repair for intact AAA for those with early
iagnosis, which was defined as at least one image more than 6 months before
urgery. Gaps in surveillance were defined as no image 1 year of surgery or no
maging for2-year time span. Hierarchic logistic regression was used to examine
ndependent predictors of rupture despite early diagnosis.
Results: Of 15,770 patients who underwent AAA repair, 1272 (8.1%)
ad repair after rupture. Of those with ruptured AAA, 34.7% had abdominal
maging6 months before rupture, compared with 61.1% for intact repair. For
atients with early diagnosis, those with ruptured AAA were older (80.2 6.9
s 77.6  6.2 years, P  .0001), received fewer images before repair (5.7 
.1 vs. 6.5 3.5, P .0001), were less likely to be treated in a high-volume
ospital (45.4% vs 59.5%, P .0001), and were more likely to have had gaps
n surveillance (47.4% vs 11.8%, P .0001) compared with those with intact
epair. After adjusting for medical comorbidities, gaps in surveillance re-
Fig.ained the strongest predictor of rupture by multivariate analysis (odds
atio, 5.97; 95% confidence interval, 4.77-7.48; P  .0001; Table).
